Clinical Report: Vaginal Microbiome Imbalance and Inflammatory Markers in Preterm Labor
Overview
This study identifies associations between vaginal microbiome dysbiosis and inflammatory markers in preterm labor patients, highlighting their potential role in predicting preterm birth. A logistic regression model demonstrated excellent predictive performance for preterm birth risk using microbiome and inflammatory markers.
Background
Preterm birth (PTB) significantly contributes to neonatal morbidity and mortality, with spontaneous preterm labor (PTL) being a major cause. Understanding the interplay between vaginal microbiome composition and immune responses is crucial for developing predictive models and interventions to mitigate PTB risk. This study aims to elucidate these relationships to enhance clinical risk stratification.
Data Highlights
Group
Dysbiosis Prevalence
MMP-9 Levels
AUC for PTB Prediction
PTL-PTB
Higher
Consistently Increased
0.910
PTL-TB
Lower
Normal
N/A
Control (TB)
Lowest
Normal
N/A
Key Findings
Dysbiosis and CST IV were more prevalent in the PTL-PTB group.
IL-1β levels were highest in CST III.
MMP-9 was consistently elevated in PTL-PTB cases and associated with dysbiosis.
IGFBP-1, MMP-8, and MMP-13 differed by clinical outcome but were not correlated with microbiome composition.
A logistic regression model using microbiome and inflammatory markers showed an AUC of 0.910 for predicting PTB.
Clinical Implications
The findings suggest that monitoring vaginal microbiome composition and inflammatory markers may aid in identifying women at risk for preterm birth. Clinicians should consider integrating these biomarkers into routine assessments for better risk stratification in patients experiencing preterm labor.
Conclusion
Distinct microbial and immune profiles are linked to the progression from preterm labor to preterm birth, with MMP-9 emerging as a critical factor. This study underscores the importance of integrated biomarker models for early risk assessment in pregnant women.
